Untreated Adult Acute Myeloid Leukemia Active Not Recruiting Phase 1 Trials for Bortezomib (DB00188)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01861314Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid LeukemiaTreatment